Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No other page content or functionality appears to be affected.
    Difference
    0.0%
    Check dated 2026-02-12T02:28:57.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Version bump from v3.4.0 to v3.4.1. No study content or user-facing information was changed.
    Difference
    0.0%
    Check dated 2026-02-04T23:55:27.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    UI and metadata text updates include adding a glossary toggle, updating the 'Last Update Submitted that Met QC Criteria' label capitalization, and displaying 'No FEAR Act Data' and 'Revision: v3.4.0' in the footer. No core study data, eligibility criteria, locations, or enrollment information were changed.
    Difference
    0.1%
    Check dated 2026-01-28T21:47:10.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study status was updated to Active, not recruiting on 2026-01-07. A new page revision (v3.3.4) was posted on 2026-01-07, replacing the previous v3.3.3 revision.
    Difference
    0.2%
    Check dated 2026-01-14T03:51:26.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Expanded recruitment sites across the US, Australia, and Europe and updated contact details; added new locations and investigators while removing some prior sites.
    Difference
    3%
    Check dated 2025-12-23T20:30:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Updated the study record with December 2025 update timestamps and removed October 2025 timestamps, reflecting routine record maintenance rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-16T14:22:30.000Z thumbnail image

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.